DK162048C - 4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse - Google Patents

4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse

Info

Publication number
DK162048C
DK162048C DK229984A DK229984A DK162048C DK 162048 C DK162048 C DK 162048C DK 229984 A DK229984 A DK 229984A DK 229984 A DK229984 A DK 229984A DK 162048 C DK162048 C DK 162048C
Authority
DK
Denmark
Prior art keywords
oxothiazolidin
preparation
yliden
procedures
acetamide derivatives
Prior art date
Application number
DK229984A
Other languages
Danish (da)
English (en)
Other versions
DK162048B (da
DK229984D0 (da
DK229984A (da
Inventor
Gerhard Satzinger
Manfred Herrmann
Edgar Fritschi
Johannes Hartenstein
Gerd Bartoszyk
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of DK229984D0 publication Critical patent/DK229984D0/da
Publication of DK229984A publication Critical patent/DK229984A/da
Publication of DK162048B publication Critical patent/DK162048B/da
Application granted granted Critical
Publication of DK162048C publication Critical patent/DK162048C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK229984A 1983-05-10 1984-05-09 4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse DK162048C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3317000 1983-05-10
DE3317000A DE3317000C2 (de) 1983-05-10 1983-05-10 4-Oxo-thiazolidin-2-yliden-acetamid-derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung von durch das Zentralnervensystem bedingten Konvulsionen

Publications (4)

Publication Number Publication Date
DK229984D0 DK229984D0 (da) 1984-05-09
DK229984A DK229984A (da) 1984-11-11
DK162048B DK162048B (da) 1991-09-09
DK162048C true DK162048C (da) 1992-02-10

Family

ID=6198604

Family Applications (1)

Application Number Title Priority Date Filing Date
DK229984A DK162048C (da) 1983-05-10 1984-05-09 4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse

Country Status (19)

Country Link
US (1) US4563471A (ru)
EP (1) EP0124911B1 (ru)
JP (1) JPS59206372A (ru)
AT (1) ATE65778T1 (ru)
AU (1) AU565799B2 (ru)
BG (2) BG41129A3 (ru)
CA (1) CA1237436A (ru)
CS (1) CS244814B2 (ru)
DD (1) DD224319A5 (ru)
DE (2) DE3317000C2 (ru)
DK (1) DK162048C (ru)
ES (2) ES532331A0 (ru)
GR (1) GR82086B (ru)
HU (1) HU190566B (ru)
IE (1) IE57372B1 (ru)
PL (2) PL142365B1 (ru)
SU (2) SU1251803A3 (ru)
YU (2) YU45183B (ru)
ZA (1) ZA843489B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269024A3 (en) * 1986-11-21 1990-05-09 Godecke Aktiengesellschaft Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
ES2092539T3 (es) * 1991-01-10 1996-12-01 Transcend Therapeutics Inc Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares.
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US6133299A (en) * 1993-02-25 2000-10-17 Warner-Lambert Company Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
KR100329808B1 (ko) * 2000-01-14 2002-03-25 박호군 2-펜아실리덴-3,5-알킬치환된-1,3-티아졸리딘-4-온의 효율적 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1150985B (de) * 1961-03-06 1963-07-04 Warner Lambert Pharmaceutical Verfahren zur Herstellung von Thiazolidin-4-on-Derivaten
FR2726M (fr) * 1962-12-04 1964-08-17 Warner Lambert Pharmaceutical Amides de thiazolidinones substituées.
DE2423725C2 (de) * 1974-05-16 1982-12-30 Gödecke AG, 1000 Berlin 5-Phenyl-4-oxo-Delta 2,ALPHA-thiazolidinessigsäureester

Also Published As

Publication number Publication date
AU565799B2 (en) 1987-10-01
YU79284A (ru) 1986-10-31
SU1251803A3 (ru) 1986-08-15
BG41129A3 (en) 1987-04-15
ES8502696A1 (es) 1985-01-16
JPS59206372A (ja) 1984-11-22
DE3484859D1 (de) 1991-09-05
DE3317000C2 (de) 1986-09-25
DK162048B (da) 1991-09-09
CA1237436A (en) 1988-05-31
EP0124911A2 (de) 1984-11-14
DD224319A5 (de) 1985-07-03
HU190566B (en) 1986-09-29
ES8502430A1 (es) 1985-01-01
PL142365B1 (en) 1987-10-31
ES532322A0 (es) 1985-01-01
YU45183B (en) 1992-05-28
ES532331A0 (es) 1985-01-16
PL142398B1 (en) 1987-10-31
ZA843489B (en) 1984-12-24
HUT34174A (en) 1985-02-28
YU63586A (en) 1986-10-31
JPS6316386B2 (ru) 1988-04-08
DE3317000A1 (de) 1984-11-15
BG40143A3 (en) 1986-10-15
ATE65778T1 (de) 1991-08-15
GR82086B (ru) 1984-12-13
PL247581A1 (en) 1985-07-16
IE57372B1 (en) 1992-08-12
SU1272985A3 (ru) 1986-11-23
CS244814B2 (en) 1986-08-14
EP0124911B1 (de) 1991-07-31
IE841150L (en) 1984-11-10
US4563471A (en) 1986-01-07
AU2788984A (en) 1984-11-15
DK229984D0 (da) 1984-05-09
EP0124911A3 (en) 1987-02-04
DK229984A (da) 1984-11-11
PL252100A1 (en) 1985-11-05

Similar Documents

Publication Publication Date Title
DK49283D0 (da) Pyrazoloxaziner, -thiaziner og - quinoliner, fremgangsmade til fremstilling deraf samt deres anvendelse som laegemidler
BR8804098A (pt) Compostos,composicoes e processo para reducao da fitotoxidez de plantas de cultura
BR8802066A (pt) Processo para preparacao de azois n-substituidos,especialmente imidazois n-substituidos
DE3769867D1 (de) Vorrichtung zur gegenseitigen ausrichtung von verschiedenfarbigen strahlbuendeln und visiereinrichtung, die diese vorrichtung enthaelt.
BR8806640A (pt) Granulados,processo para tratamento fitossanitario e processo para preparacao de granulados
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
DK550586A (da) Laegemiddel til behandling af neuropsykiatriske tilstande, saasom demens
DK314887A (da) Kompleksforbindelser, farmaceutiske midler med indhold heraf samt fremgangsmaade til fremstilling heraf
DK162048C (da) 4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
ES2086359T3 (es) R(-)-1-(5-hidroxihexil)-3-metil-7-propilxantina, procedimiento para su preparacion y medicamentos que contienen este compuesto.
EP0267297A4 (en) SIALOSYLCHOLESTEROL, PROCESS FOR THE PREPARATION AND MEDICINE AGAINST DISORDERS OF THE NERVOUS SYSTEM.
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
DK585984A (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
DK450086D0 (da) 12- og 13-bromergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse
DK142683A (da) N,n,n-trialkylammonium-derivater af n-epoxymethan, fremgangsmaade til fremstilling af saadanne derivater og anvendelse heraf til behandling af polyhydroxylerede og polyaminerede polymere
DE3878529D1 (de) Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.
DE68919887D1 (de) Verfahren zur Herstellung von 1-alpha,25-dihydroxy-vitamin D2 und dessen 24-Epimer.
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater
BR8206066A (pt) Processo para producao ou tratamento de ferrocromo
DK280683A (da) Azolsubstituerede oximino-cyan-acetamid-derivater, fremgangsmaader til fremstilling deraf samt deres anvendelse som fungicider
NO166447C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomt n-(1-cyclohexenylmethyl-2-pyrrolidinylmethyl)-8-ethylsulfonyl-1,5-benzodioxepan-6-carboxamid.
DZ1230A1 (fr) Procédé de préparation des cis-n-(3-méthoxy-4-pipéridinyl benzamides.
ATE94558T1 (de) Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems.
BR7908996A (pt) Composicao farmaceutica,processo de preparacao de compostos farmaceuticos,processo de prevencao e/ou tratamento de doencas,compostos farmaceutico e processo de prevencao e/ou tratamento de hipocolesterolemia

Legal Events

Date Code Title Description
PBP Patent lapsed